Accordingly, it is plausible that the AA signal can be presumed to be higher compared with other traditional cancer blood-based protein biomarkers, such as carcinoembryonic antigen, carbohydrate antigen 19-9 l and α-fetoprotein, alone [21–28]. The gene discussed is CEACAM5; the disease is cancer.